Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
163.02
+0.77 (0.47%)
At close: Feb 21, 2025, 4:00 PM
165.15
+2.13 (1.31%)
After-hours: Feb 21, 2025, 7:24 PM EST
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$201,492
Profits / Employee
$512
Market Cap
8.34B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CRL News
- 2 days ago - Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance - Benzinga
- 2 days ago - Charles River Laboratories International, Inc. (CRL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Charles River beats quarterly estimates on stable demand for drug development services - Reuters
- 3 days ago - Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance - Business Wire
- 11 days ago - Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions - Business Wire
- 24 days ago - Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call - Business Wire
- 4 weeks ago - Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences - Business Wire
- 5 weeks ago - Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform - Business Wire